Transporters as mediators of drug resistance in Plasmodium falciparum

International Journal for Parasitology

Volumn 40, Issue 10, 2010, Pages 1109-1118

  Sanchez, Cecilia P ^a   Dave, Anurag ^a   Stein, Wilfred D ^b   Lanzer, Michael ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Drug resistance; Malaria; PfCRT; PfMDR1; PfMRP; Transport

Indexed keywords

AMANTADINE; AMODIAQUINE; ARTEMISININ; BENFLUMETOL; CHLOROQUINE; CHLOROQUINE RESISTANCE TRANSPORTER; GLUTATHIONE; HALOFANTRINE; MEFLOQUINE; MEMBRANE PROTEIN; MEPACRINE; MULTIDRUG RESISTANCE PROTEIN 1; PIPERAQUINE; PRIMAQUINE; QUINIDINE; QUININE; UNCLASSIFIED DRUG; VERAPAMIL;

DRUG RESISTANCE; MALARIA; MUTATION; PHENOTYPE; PROTEIN;

AMINO ACID SUBSTITUTION; ANTIMALARIAL DRUG RESISTANCE; ANTIMALARIAL DRUG SUSCEPTIBILITY; DRUG ACCUMULATION; DRUG BINDING SITE; DRUG TRANSPORT; ENZYME SPECIFICITY; GENE MUTATION; GENETIC POLYMORPHISM; HUMAN; MEMBRANE TRANSPORT; MEMBRANE VESICLE; MULTIDRUG RESISTANCE; NONHUMAN; PLASMODIUM FALCIPARUM; PROTON TRANSPORT; REVIEW;

ANIMALS; ANTIMALARIALS; DRUG RESISTANCE; GENE EXPRESSION REGULATION; MEMBRANE TRANSPORT PROTEINS; PLASMODIUM FALCIPARUM;

PLASMODIUM FALCIPARUM;

EID: 77954029768     PISSN: 00207519     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpara.2010.04.001     Document Type: Review

References (116)

1. Ambudkar S.V., Kimchi-Sarfaty C., Sauna Z.E., Gottesman M.M. P-glycoprotein: from genomics to mechanism. Oncogene 2003, 22:7468-7485.
2. Bennett T.N., Kosar A.D., Ursos L.M., Dzekunov S., Singh Sidhu A.B., Fidock D.A., Roepe P.D. Drug resistance-associated pfCRT mutations confer decreased Plasmodium falciparum digestive vacuolar pH. Mol. Biochem. Parasitol. 2004, 133:99-114.
3. Bhattacharjee A.K., Kyle D.E., Vennerstrom J.L., Milhous W.K. A 3D QSAR pharmacophore model and quantum chemical structure-activity analysis of chloroquine(CQ)-resistance reversal. J. Chem. Inf. Comput. Sci. 2002, 42:1212-1220.
4. Bloland, P.B., 2001. Drug resistance in malaria. World Health Organization WHO/CDC/DRS/2001.4.
5. Bray P.G., Mungthin M., Ridley R.G., Ward S.A. Access to hematin: the basis of chloroquine resistance. Mol. Pharmacol. 1998, 54:170-179.
6. Bray P.G., Saliba K.J., Davies J.D., Spiller D.G., White M.R., Kirk K., Ward S.A. Distribution of acridine orange fluorescence in Plasmodium falciparum-infected erythrocytes and its implications for the evaluation of digestive vacuole pH. Mol. Biochem. Parasitol. 2002, 119:301-304.
7. Bray P.G., Mungthin M., Hastings I.M., Biagini G.A., Saidu D.K., Lakshmanan V., Johnson D.J., Hughes R.H., Stocks P.A., O'Neill P.M., Fidock D.A., Warhurst D.C., Ward S.A. PfCRT and the trans-vacuolar proton electrochemical gradient: regulating the access of chloroquine to ferriprotoporphyrin IX. Mol. Microbiol. 2006, 62:238-251.
8. Cabrera M., Paguio M.F., Xie C., Roepe P.D. Reduced digestive vacuolar accumulation of chloroquine is not linked to resistance to chloroquine toxicity. Biochemistry 2009, 48:11152-11154.
9. Chattopadhyay R., Kumar S. Malaria vaccine: latest update and challenges ahead. Indian J. Exp. Biol. 2009, 47:527-536.
10. Chen N., Kyle D.E., Pasay C., Fowler E.V., Baker J., Peters J.M., Cheng Q. Pfcrt allelic types with two novel amino acid mutations in chloroquine-resistant Plasmodium falciparum isolates from the Philippines. Antimicrob. Agents Chemother. 2003, 47:3500-3505.
11. Chou A.C., Chevli R., Fitch C.D. Ferriprotoporphyrin IX fulfills the criteria for identification as the chloroquine receptor of malaria parasites. Biochemistry 1980, 19:1543-1549.
12. Cooper R.A., Ferdig M.T., Su X.Z., Ursos L.M., Mu J., Nomura T., Fujioka H., Fidock D.A., Roepe P.D., Wellems T.E. Alternative mutations at position 76 of the vacuolar transmembrane protein PfCRT are associated with chloroquine resistance and unique stereospecific quinine and quinidine responses in Plasmodium falciparum. Mol. Pharmacol. 2002, 61:35-42.
13. Cooper R.A., Lane K.D., Deng B., Mu J., Patel J.J., Wellems T.E., Su X., Ferdig M.T. Mutations in transmembrane domains 1, 4 and 9 of the Plasmodium falciparum chloroquine resistance transporter alter susceptibility to chloroquine, quinine and quinidine. Mol. Microbiol. 2007, 63:270-282.
14. Cowman A.F., Karcz S., Galatis D., Culvenor J.G. A P-glycoprotein homologue of Plasmodium falciparum is localized on the digestive vacuole. J. Cell Biol. 1991, 113:1033-1042.
15. Cowman A.F., Galatis D., Thompson J.K. Selection for mefloquine resistance in Plasmodium falciparum is linked to amplification of the pfmdr1 gene and cross-resistance to halofantrine and quinine. Proc. Natl. Acad. Sci. USA 1994, 91:1143-1147.
16. De D., Krogstad F.M., Cogswell F.B., Krogstad D.J. Aminoquinolines that circumvent resistance in Plasmodium falciparum in vitro. Am. J. Trop. Med. Hyg. 1996, 55:579-583.
17. de Duve C., de Barsy T., Poole B., Trouet A., Tulkens P., Van Hoof F. Commentary. Lysosomotropic agents. Biochem. Pharmacol. 1974, 23:2495-2531.
18. Dondorp A.M., Nosten F., Yi P., Das D., Phyo A.P., Tarning J., Lwin K.M., Ariey F., Hanpithakpong W., Lee S.J., Ringwald P., Silamut K., Imwong M., Chotivanich K., Lim P., Herdman T., An S.S., Yeung S., Singhasivanon P., Day N.P., Lindegardh N., Socheat D., White N.J. Artemisinin resistance in Plasmodium falciparum malaria. N. Engl. J. Med. 2009, 361:455-467.
19. Duraisingh M.T., Jones P., Sambou I., von Seidlein L., Pinder M., Warhurst D.C. The tyrosine-86 allele of the pfmdr1 gene of Plasmodium falciparum is associated with increased sensitivity to the anti-malarials mefloquine and artemisinin. Mol. Biochem. Parasitol. 2000, 108:13-23.
20. Duraisingh M.T., Cowman A.F. Contribution of the pfmdr1 gene to antimalarial drug-resistance. Acta Trop. 2005, 94:181-190.
21. Dzekunov S.M., Ursos L.M., Roepe P.D. Digestive vacuolar pH of intact intraerythrocytic P. Falciparum either sensitive or resistant to chloroquine. Mol. Biochem. Parasitol. 2000, 110:107-124.
22. Eckstein-Ludwig U., Webb R.J., Van Goethem I.D., East J.M., Lee A.G., Kimura M., O'Neill P.M., Bray P.G., Ward S.A., Krishna S. Artemisinins target the SERCA of Plasmodium falciparum. Nature 2003, 424:957-961.
23. Ekland E.H., Fidock D.A. Advances in understanding the genetic basis of antimalarial drug resistance. Curr. Opin. Microbiol. 2007, 10:363-370.
24. Ferdig M.T., Cooper R.A., Mu J., Deng B., Joy D.A., Su X.Z., Wellems T.E. Dissecting the loci of low-level quinine resistance in malaria parasites. Mol. Microbiol. 2004, 52:985-997.
25. Ferrari V., Cutler D.J. Simulation of kinetic data on the influx and efflux of chloroquine by erythrocytes infected with Plasmodium falciparum. Evidence for a drug-importer in chloroquine-sensitive strains. Biochem. Pharmacol. 1991, 42(Suppl.):S167-S179.
26. Fidock D.A., Nomura T., Talley A.K., Cooper R.A., Dzekunov S.M., Ferdig M.T., Ursos L.M., Sidhu A.B., Naude B., Deitsch K.W., Su X.Z., Wootton J.C., Roepe P.D., Wellems T.E. Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance. Mol. Cell 2000, 6:861-871.
27. Fitch C.D. Ferriprotoporphyrin IX, phospholipids, and the antimalarial actions of quinoline drugs. Life Sci. 2004, 74:1957-1972.
28. Foote S.J., Thompson J.K., Cowman A.F., Kemp D.J. Amplification of the multidrug resistance gene in some chloroquine-resistant isolates of P. falciparum. Cell 1989, 57:921-930.
29. Foote S.J., Kyle D.E., Martin R.K., Oduola A.M., Forsyth K., Kemp D.J., Cowman A.F. Several alleles of the multidrug-resistance gene are closely linked to chloroquine resistance in Plasmodium falciparum. Nature 1990, 345:255-258.
30. Hayeshi R., Masimirembwa C., Mukanganyama S., Ungell A.L. The potential inhibitory effect of antiparasitic drugs and natural products on P-glycoprotein mediated efflux. Eur. J. Pharm. Sci. 2006, 29:70-81.
31. Hayward R., Saliba K.J., Kirk K. Pfmdr1 mutations associated with chloroquine resistance incur a fitness cost in Plasmodium falciparum. Mol. Microbiol. 2005, 55:1285-1295.
32. Hayward R., Saliba K.J., Kirk K. The pH of the digestive vacuole of Plasmodium falciparum is not associated with chloroquine resistance. J. Cell Sci. 2006, 119:1016-1025.
33. Higgins C.F. Multiple molecular mechanisms for multidrug resistance transporters. Nature 2007, 446:749-757.
34. Jambou R., Legrand E., Niang M., Khim N., Lim P., Volney B., Ekala M.T., Bouchier C., Esterre P., Fandeur T., Mercereau-Puijalon O. Resistance of Plasmodium falciparum field isolates to in-vitro artemether and point mutations of the SERCA-type PfATPase6. Lancet 2005, 366:1960-1963.
35. Jani D., Nagarkatti R., Beatty W., Angel R., Slebodnick C., Andersen J., Kumar S., Rathore D. HDP-a novel heme detoxification protein from the malaria parasite. PLoS Pathog. 2008, 4:e1000053.
36. Johnson D.J., Fidock D.A., Mungthin M., Lakshmanan V., Sidhu A.B., Bray P.G., Ward S.A. Evidence for a central role for PfCRT in conferring Plasmodium falciparum resistance to diverse antimalarial agents. Mol. Cell 2004, 15:867-877.
37. Karcz S.R., Galatis D., Cowman A.F. Nucleotide binding properties of a P-glycoprotein homologue from Plasmodium falciparum. Mol. Biochem. Parasitol. 1993, 58:269-276.
38. Kavishe R.A., van den Heuvel J.M., van de Vegte-Bolmer M., Luty A.J., Russel F.G., Koenderink J.B. Localization of the ATP-binding cassette (ABC) transport proteins PfMRP1, PfMRP2, and PfMDR5 at the Plasmodium falciparum plasma membrane. Malar. J. 2009, 8:205.
39. Klonis N., Tan O., Jackson K., Goldberg D., Klemba M., Tilley L. Evaluation of pH during cytostomal endocytosis and vacuolar catabolism of haemoglobin in Plasmodium falciparum. Biochem. J. 2007, 407:343-354.
40. Krishna S., Bustamante L., Haynes R.K., Staines H.M. Artemisinins: their growing importance in medicine. Trends Pharmacol. Sci. 2008, 29:520-527.
41. Krishnamurthy H., Piscitelli C.L., Gouaux E. Unlocking the molecular secrets of sodium-coupled transporters. Nature 2009, 459:347-355.
42. Krogstad D.J., Schlesinger P.H., Gluzman I.Y. Antimalarials increase vesicle pH in Plasmodium falciparum. J. Cell Biol. 1985, 101:2302-2309.
43. Krogstad D.J., Gluzman I.Y., Kyle D.E., Oduola A.M., Martin S.K., Milhous W.K., Schlesinger P.H. Efflux of chloroquine from Plasmodium falciparum: mechanism of chloroquine resistance. Science 1987, 238:1283-1285.
44. Kuhn Y., Rohrbach P., Lanzer M. Quantitative pH measurements in Plasmodium falciparum-infected erythrocytes using pHluorin. Cell. Microbiol. 2007, 9:1004-1013.
45. Kuhn Y., Sanchez C.P., Ayoub D., Saridaki T., van Dorsselaer A., Lanzer M. Trafficking of the phosphoprotein PfCRT to the digestive vacuolar membrane in Plasmodium falciparum. Traffic 2010, 11:236-249.
46. Lakshmanan V., Bray P.G., Verdier-Pinard D., Johnson D.J., Horrocks P., Muhle R.A., Alakpa G.E., Hughes R.H., Ward S.A., Krogstad D.J., Sidhu A.B., Fidock D.A. A critical role for PfCRT K76T in Plasmodium falciparum verapamil-reversible chloroquine resistance. EMBO J. 2005, 24:2294-2305.
47. Lehane A.M., Hayward R., Saliba K.J., Kirk K. A verapamil-sensitive chloroquine-associated H+ leak from the digestive vacuole in chloroquine-resistant malaria parasites. J. Cell Sci. 2008, 121:1624-1632.
48. Lehane A.M., Kirk K. Chloroquine resistance-conferring mutations in pfcrt give rise to a chloroquine-associated H+ leak from the malaria parasite's digestive vacuole. Antimicrob. Agents Chemother. 2008, 52:4374-4380.
49. Lekostaj J.K., Natarajan J.K., Paguio M.F., Wolf C., Roepe P.D. Photoaffinity labeling of the Plasmodium falciparum chloroquine resistance transporter with a novel perfluorophenylazido chloroquine. Biochemistry 2008, 47:10394-10406.
50. Lew V.L., Tiffert T., Ginsburg H. Excess hemoglobin digestion and the osmotic stability of Plasmodium falciparum-infected red blood cells. Blood 2003, 101:4189-4194.
51. Liu D.Q., Liu R.J., Ren D.X., Gao D.Q., Zhang C.Y., Qui C.P., Cai X.Z., Ling C.F., Song A.H., Tang X. Changes in the resistance of Plasmodium falciparum to chloroquine in Hainan, China. Bull. World Health Organ. 1995, 73:483-486.
52. Liu J., Istvan E.S., Gluzman I.Y., Gross J., Goldberg D.E. Plasmodium falciparum ensures its amino acid supply with multiple acquisition pathways and redundant proteolytic enzyme systems. Proc. Natl. Acad. Sci. USA 2006, 103:8840-8845.
53. Loo T.W., Clarke D.M. Recent progress in understanding the mechanism of P-glycoprotein-mediated drug efflux. J. Membr. Biol. 2005, 206:173-185.
54. Martin R.E., Kirk K. The malaria parasite's chloroquine resistance transporter is a member of the drug/metabolite transporter superfamily. Mol. Biol. Evol. 2004, 21:1938-1949.
55. Martin R.E., Ginsburg H., Kirk K. Membrane transport proteins of the malaria parasite. Mol. Microbiol. 2009, 74:519-528.
56. Martin R.E., Marchetti R.V., Cowan A.I., Howitt S.M., Broer S., Kirk K. Chloroquine transport via the malaria parasite's chloroquine resistance transporter. Science 2009, 325:1680-1682.
57. Maughan S.C., Pasternak M., Cairns N., Kiddle G., Brach T., Jarvis R., Haas F., Nieuwland J., Lim B., Muller C., Salcedo-Sora E., Kruse C., Orsel M., Hell R., Miller A.J., Bray P., Foyer C.H., Murray J.A., Meyer A.J., Cobbett C.S. Plant homologs of the Plasmodium falciparum chloroquine-resistance transporter, PfCRT, are required for glutathione homeostasis and stress responses. Proc. Natl. Acad. Sci. USA 2010, 107:2331-2336.
58. Mehlotra R.K., Fujioka H., Roepe P.D., Janneh O., Ursos L.M., Jacobs-Lorena V., McNamara D.T., Bockarie M.J., Kazura J.W., Kyle D.E., Fidock D.A., Zimmerman P.A. Evolution of a unique Plasmodium falciparum chloroquine-resistance phenotype in association with pfcrt polymorphism in Papua New Guinea and South America. Proc. Natl. Acad. Sci. USA 2001, 98:12689-12694.
59. Meierjohann S., Walter R.D., Muller S. Regulation of intracellular glutathione levels in erythrocytes infected with chloroquine-sensitive and chloroquine-resistant Plasmodium falciparum. Biochem. J. 2002, 368:761-768.
60. Mita T., Kaneko A., Lum J.K., Bwijo B., Takechi M., Zungu I.L., Tsukahara T., Tanabe K., Kobayakawa T., Bjorkman A. Recovery of chloroquine sensitivity and low prevalence of the Plasmodium falciparum chloroquine resistance transporter gene mutation K76T following the discontinuance of chloroquine use in Malawi. Am. J. Trop. Med. Hyg. 2003, 68:413-415.
61. Mita T., Kaneko A., Lum J.K., Zungu I.L., Tsukahara T., Eto H., Kobayakawa T., Bjorkman A., Tanabe K. Expansion of wild type allele rather than back mutation in pfcrt explains the recent recovery of chloroquine sensitivity of Plasmodium falciparum in Malawi. Mol. Biochem. Parasitol. 2004, 135:159-163.
62. Mita T., Tanabe K., Takahashi N., Culleton R., Ndounga M., Dzodzomenyo M., Akhwale W.S., Kaneko A., Kobayakawa T. Indigenous evolution of Plasmodium falciparum pyrimethamine resistance multiple times in Africa. J. Antimicrob. Chemother. 2009, 63:252-255.
63. Mu J., Ferdig M.T., Feng X., Joy D.A., Duan J., Furuya T., Subramanian G., Aravind L., Cooper R.A., Wootton J.C., Xiong M., Su X.Z. Multiple transporters associated with malaria parasite responses to chloroquine and quinine. Mol. Microbiol. 2003, 49:977-989.
64. Naude B., Brzostowski J.A., Kimmel A.R., Wellems T.E. Dictyostelium discoideum expresses a malaria chloroquine resistance mechanism upon transfection with mutant, but not wild-type, Plasmodium falciparum transporter PfCRT. J. Biol. Chem. 2005, 280:25596-25603.
65. Nessler S., Friedrich O., Bakouh N., Fink R.H., Sanchez C.P., Planelles G., Lanzer M. Evidence for activation of endogenous transporters in Xenopus laevis oocytes expressing the Plasmodium falciparum chloroquine resistance transporter, PfCRT. J. Biol. Chem. 2004, 279:39438-39446.
66. Ngo T., Duraisingh M., Reed M., Hipgrave D., Biggs B., Cowman A.F. Analysis of pfcrt, pfmdr1, dhfr, and dhps mutations and drug sensitivities in Plasmodium falciparum isolates from patients in Vietnam before and after treatment with artemisinin. Am. J. Trop. Med. Hyg. 2003, 68:350-356.
67. Noedl H., Se Y., Schaecher K., Smith B.L., Socheat D., Fukuda M.M. Evidence of artemisinin-resistant malaria in western Cambodia. N. Engl. J. Med. 2008, 359:2619-2620.
68. Paguio M.F., Cabrera M., Roepe P.D. Chloroquine transport in Plasmodium falciparum. 2. Analysis of PfCRT-mediated drug transport using proteoliposomes and a fluorescent chloroquine probe. Biochemistry 2009, 48:9482-9491.
69. Pickard A.L., Wongsrichanalai C., Purfield A., Kamwendo D., Emery K., Zalewski C., Kawamoto F., Miller R.S., Meshnick S.R. Resistance to antimalarials in Southeast Asia and genetic polymorphisms in pfmdr1. Antimicrob. Agents Chemother. 2003, 47:2418-2423.
70. Picot S., Olliaro P., de Monbrison F., Bienvenu A.L., Price R.N., Ringwald P. A systematic review and meta-analysis of evidence for correlation between molecular markers of parasite resistance and treatment outcome in falciparum malaria. Malar. J. 2009, 8:89.
71. Price R.N., Uhlemann A.C., Brockman A., McGready R., Ashley E., Phaipun L., Patel R., Laing K., Looareesuwan S., White N.J., Nosten F., Krishna S. Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number. Lancet 2004, 364:438-447.
72. Raj D.K., Mu J., Jiang H., Kabat J., Singh S., Sullivan M., Fay M.P., McCutchan T.F., Su X.Z. Disruption of a Plasmodium falciparum multidrug resistance-associated protein (PfMRP) alters its fitness and transport of antimalarial drugs and glutathione. J. Biol. Chem. 2009, 284:7687-7696.
73. Rathod P.K., McErlean T., Lee P.C. Variations in frequencies of drug resistance in Plasmodium falciparum. Proc. Natl. Acad. Sci. USA 1997, 94:9389-9393.
74. Reed M.B., Saliba K.J., Caruana S.R., Kirk K., Cowman A.F. Pgh1 modulates sensitivity and resistance to multiple antimalarials in Plasmodium falciparum. Nature 2000, 403:906-909.
75. Ridley R.G., Hofheinz W., Matile H., Jaquet C., Dorn A., Masciadri R., Jolidon S., Richter W.F., Guenzi A., Girometta M.A., Urwyler H., Huber W., Thaithong S., Peters W. 4-Aminoquinoline analogs of chloroquine with shortened side chains retain activity against chloroquine-resistant Plasmodium falciparum. Antimicrob. Agents Chemother. 1996, 40:1846-1854.
76. Roepe P.D. Molecular and physiologic basis of quinoline drug resistance in Plasmodium falciparum malaria. Future Microbiol. 2009, 4:441-455.
77. Rohrbach P., Sanchez C.P., Hayton K., Friedrich O., Patel J., Sidhu A.B., Ferdig M.T., Fidock D.A., Lanzer M. Genetic linkage of pfmdr1 with food vacuolar solute import in Plasmodium falciparum. EMBO J. 2006, 25:3000-3011.
78. Rosenberg E., Litus I., Schwarzfuchs N., Sinay R., Schlesinger P., Golenser J., Baumeister S., Lingelbach K., Pollack Y. Pfmdr2 confers heavy metal resistance to Plasmodium falciparum. J. Biol. Chem. 2006, 281:27039-27045.
79. Rubio J.P., Cowman A.F. Plasmodium falciparum: the pfmdr2 protein is not overexpressed in chloroquine-resistant isolates of the malaria parasite. Exp. Parasitol. 1994, 79:137-147.
80. Rubio J.P., Cowman A.F. The ATP-binding cassette (ABC) gene family of Plasmodium falciparum. Parasitol. Today 1996, 12:135-140.
81. Sa J.M., Twu O., Hayton K., Reyes S., Fay M.P., Ringwald P., Wellems T.E. Geographic patterns of Plasmodium falciparum drug resistance distinguished by differential responses to amodiaquine and chloroquine. Proc. Natl. Acad. Sci. USA 2009, 106:18883-18889.
82. Saliba K.J., Kirk K. pH regulation in the intracellular malaria parasite, Plasmodium falciparum. H(+) extrusion via a v-type H(+)-atpase. J. Biol. Chem. 1999, 274:33213-33219.
83. Saliba K.J., Allen R.J., Zissis S., Bray P.G., Ward S.A., Kirk K. Acidification of the malaria parasite's digestive vacuole by a H+-ATPase and a H+-pyrophosphatase. J. Biol. Chem. 2003, 278:5605-5612.
84. Sanchez C.P., Stein W., Lanzer M. Trans stimulation provides evidence for a drug efflux carrier as the mechanism of chloroquine resistance in Plasmodium falciparum. Biochemistry 2003, 42:9383-9394.
85. Sanchez C.P., McLean J.E., Stein W., Lanzer M. Evidence for a substrate specific and inhibitable drug efflux system in chloroquine resistant Plasmodium falciparum strains. Biochemistry 2004, 43:16365-16373.
86. Sanchez C.P., McLean J.E., Rohrbach P., Fidock D.A., Stein W.D., Lanzer M. Evidence for a pfcrt-associated chloroquine efflux system in the human malarial parasite Plasmodium falciparum. Biochemistry 2005, 44:9862-9870.
87. Sanchez C.P., Rohrbach P., McLean J.E., Fidock D.A., Stein W.D., Lanzer M. Differences in trans-stimulated chloroquine efflux kinetics are linked to PfCRT in Plasmodium falciparum. Mol. Microbiol. 2007, 64:407-420.
88. Sanchez C.P., Stein W.D., Lanzer M. Is PfCRT a channel or a carrier? Two competing models explaining chloroquine resistance in Plasmodium falciparum. Trends Parasitol. 2007, 23:332-339.
89. Sanchez C.P., Stein W.D., Lanzer M. Dissecting the components of quinine accumulation in Plasmodium falciparum. Mol. Microbiol. 2008, 67:1081-1093.
90. Sanchez C.P., Rotmann A., Stein W.D., Lanzer M. Polymorphisms within PfMDR1 alter the substrate specificity for anti-malarial drugs in Plasmodium falciparum. Mol. Microbiol. 2008, 70:786-798.
91. Schulz B., Kolukisaoglu H.U. Genomics of plant ABC transporters: the alphabet of photosynthetic life forms or just holes in membranes?. FEBS Lett. 2006, 580:1010-1016.
92. Sidhu A.B., Verdier-Pinard D., Fidock D.A. Chloroquine resistance in Plasmodium falciparum malaria parasites conferred by pfcrt mutations. Science 2002, 298:210-213.
93. Sidhu A.B., Valderramos S.G., Fidock D.A. Pfmdr1 mutations contribute to quinine resistance and enhance mefloquine and artemisinin sensitivity in Plasmodium falciparum. Mol. Microbiol. 2005, 57:913-926.
94. Sidhu A.B., Uhlemann A.C., Valderramos S.G., Valderramos J.C., Krishna S., Fidock D.A. Decreasing pfmdr1 copy number in Plasmodium falciparum malaria heightens susceptibility to mefloquine, lumefantrine, halofantrine, quinine, and artemisinin. J. Infect. Dis. 2006, 194:528-535.
95. Sisowath C., Stromberg J., Martensson A., Msellem M., Obondo C., Bjorkman A., Gil J.P. In vivo selection of Plasmodium falciparum pfmdr1 86N coding alleles by artemether-lumefantrine (Coartem). J. Infect. Dis. 2005, 191:1014-1017.
96. Snow R.W., Guerra C.A., Noor A.M., Myint H.Y., Hay S.I. The global distribution of clinical episodes of Plasmodium falciparum malaria. Nature 2005, 434:214-217.
97. Stein W.D. Transport and Diffusion Across Cell Membranes 1986, Academic Press, New York.
98. Tan W., Gou D.M., Tai E., Zhao Y.Z., Chow L.M. Functional reconstitution of purified chloroquine resistance membrane transporter expressed in yeast. Arch. Biochem. Biophys. 2006, 452:119-128.
99. Tran C.V., Saier M.H. The principal chloroquine resistance protein of Plasmodium falciparum is a member of the drug/metabolite transporter superfamily. Microbiology 2004, 150:1-3.
100. Uhlemann A.C., Cameron A., Eckstein-Ludwig U., Fischbarg J., Iserovich P., Zuniga F.A., East M., Lee A., Brady L., Haynes R.K., Krishna S. A single amino acid residue can determine the sensitivity of SERCAs to artemisinins. Nat. Struct. Mol. Biol. 2005, 12:628-629.
101. Valderramos S.G., Fidock D.A. Transporters involved in resistance to antimalarial drugs. Trends Pharmacol. Sci. 2006, 27:594-601.
102. van Es H.H., Karcz S., Chu F., Cowman A.F., Vidal S., Gros P., Schurr E. Expression of the plasmodial pfmdr1 gene in mammalian cells is associated with increased susceptibility to chloroquine. Mol. Cell. Biol. 1994, 14:2419-2428.
103. van Schalkwyk D.A., Egan T.J. Quinoline-resistance reversing agents for the malaria parasite Plasmodium falciparum. Drug Resist. Updat. 2006, 9:211-226.
104. Volkman S.K., Cowman A.F., Wirth D.F. Functional complementation of the ste6 gene of Saccharomyces cerevisiae with the pfmdr1 gene of Plasmodium falciparum. Proc. Natl. Acad. Sci. USA 1995, 92:8921-8925.
105. Warhurst D.C., Craig J.C., Adagu I.S. Lysosomes and drug resistance in malaria. Lancet 2002, 360:1527-1529.
106. Weaver J.L., Szabo G., Pine P.S., Gottesman M.M., Goldenberg S., Aszalos A. The effect of ion channel blockers, immunosuppressive agents, and other drugs on the activity of the multi-drug transporter. Int. J. Cancer 1993, 54:456-461.
107. Wellems T.E., Hayton K., Fairhurst R.M. The impact of malaria parasitism: from corpuscles to communities. J. Clin. Invest. 2009, 119:2496-2505.
108. Wilson C.M., Serrano A.E., Wasley A., Bogenschutz M.P., Shankar A.H., Wirth D.F. Amplification of a gene related to mammalian mdr genes in drug-resistant Plasmodium falciparum. Science 1989, 244:1184-1186.
109. Wilson C.M., Volkman S.K., Thaithong S., Martin R.K., Kyle D.E., Milhous W.K., Wirth D.F. Amplification of pfmdr 1 associated with mefloquine and halofantrine resistance in Plasmodium falciparum from Thailand. Mol. Biochem. Parasitol. 1993, 57:151-160.
110. Wissing F., Sanchez C.P., Rohrbach P., Ricken S., Lanzer M. Illumination of the malaria parasite Plasmodium falciparum alters intracellular pH. Implications for live cell imaging. J. Biol. Chem. 2002, 277:37747-37755.
111. Wootton J.C., Feng X., Ferdig M.T., Cooper R.A., Mu J., Baruch D.I., Magill A.J., Su X.Z. Genetic diversity and chloroquine selective sweeps in Plasmodium falciparum. Nature 2002, 418:320-323.
112. World Health Organization, W.H., 2006. Guidelines for the treatment of malaria. World Health Organization.
113. Yayon A., Cabantchik Z.I., Ginsburg H. Identification of the acidic compartment of Plasmodium falciparum-infected human erythrocytes as the target of the antimalarial drug chloroquine. EMBO J. 1984, 3:2695-2700.
114. Yayon A., Cabantchik Z.I., Ginsburg H. Susceptibility of human malaria parasites to chloroquine is pH dependent. Proc. Natl. Acad. Sci. USA 1985, 82:2784-2788.
115. Yuan J., Johnson R.L., Huang R., Wichterman J., Jiang H., Hayton K., Fidock D.A., Wellems T.E., Inglese J., Austin C.P., Su X.Z. Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum. Nat. Chem. Biol. 2009, 5:765-771.
116. Zhang H., Paguio M., Roepe P.D. The antimalarial drug resistance protein Plasmodium falciparum chloroquine resistance transporter binds chloroquine. Biochemistry 2004, 43:8290-8296.